Your browser is no longer supported. Please, upgrade your browser.
Settings
MCK McKesson Corporation daily Stock Chart
MCK [NYSE]
McKesson Corporation
IndexS&P 500 P/E16.09 EPS (ttm)8.91 Insider Own0.29% Shs Outstand225.33M Perf Week0.18%
Market Cap32.30B Forward P/E11.38 EPS next Y12.59 Insider Trans-24.46% Shs Float225.15M Perf Month10.05%
Income2.04B PEG1.77 EPS next Q2.92 Inst Own86.60% Short Float1.73% Perf Quarter-18.44%
Sales194.27B P/S0.17 EPS this Y30.10% Inst Trans0.31% Short Ratio1.37 Perf Half Y-22.45%
Book/sh41.81 P/B3.43 EPS next Y0.30% ROA3.40% Target Price156.64 Perf Year-22.85%
Cash/sh24.25 P/C5.91 EPS next 5Y9.10% ROE21.00% 52W Range114.31 - 200.83 Perf YTD-26.83%
Dividend1.12 P/FCF7.26 EPS past 5Y18.00% ROI15.50% 52W High-28.63% Beta1.07
Dividend %0.78% Quick Ratio0.70 Sales past 5Y11.20% Gross Margin5.90% 52W Low25.40% ATR4.31
Employees68000 Current Ratio1.10 Sales Q/Q2.50% Oper. Margin1.70% RSI (14)48.09 Volatility2.53% 2.76%
OptionableYes Debt/Eq0.86 EPS Q/Q-49.00% Profit Margin1.00% Rel Volume1.03 Prev Close141.62
ShortableYes LT Debt/Eq0.63 EarningsOct 27 AMC Payout13.30% Avg Volume2.83M Price143.34
Recom2.80 SMA200.52% SMA50-4.04% SMA200-15.65% Volume2,902,900 Change1.21%
Nov-23-16Downgrade Credit Suisse Neutral → Underperform
Nov-11-16Downgrade Standpoint Research Buy → Hold
Nov-09-16Upgrade Mizuho Neutral → Buy $147
Oct-28-16Upgrade Standpoint Research Hold → Buy
Oct-28-16Downgrade Robert W. Baird Outperform → Neutral $200 → $164
Oct-28-16Downgrade Leerink Partners Outperform → Mkt Perform
Oct-28-16Downgrade Deutsche Bank Buy → Hold $196 → $153
Sep-26-16Reiterated Mizuho Neutral $197 → $183
Sep-16-16Downgrade Goldman Buy → Neutral
Aug-11-16Reiterated Mizuho Neutral $174 → $197
Jun-07-16Resumed BofA/Merrill Neutral
Jun-07-16Reiterated Mizuho Neutral $164 → $174
May-05-16Downgrade Avondale Mkt Outperform → Mkt Perform
Apr-26-16Downgrade Standpoint Research Buy → Hold
Apr-19-16Initiated Avondale Mkt Outperform $203
Mar-16-16Initiated Credit Suisse Neutral
Mar-01-16Downgrade Mizuho Buy → Neutral $164
Feb-10-16Upgrade Standpoint Research Hold → Buy $184
Jan-15-16Reiterated Mizuho Buy $210 → $193
Jan-12-16Reiterated RBC Capital Mkts Outperform $220 → $190
Dec-02-16 12:48PM  ETFs with exposure to McKesson Corp. : December 2, 2016
Nov-28-16 10:03AM  Is General Dynamics Corporation (GD) A Good Stock To Buy? at Insider Monkey
Nov-26-16 10:29PM  Vulcan Value Partners Talks Oracle (ORCL)s Value, Plus New Positions in McKesson (MCK), Qorvo (QRVO), More at Insider Monkey
Nov-25-16 07:42AM  Hedge Funds Are Dumping Aetna Inc. (AET) at Insider Monkey
Nov-23-16 09:51AM  Credit Suisse Cuts McKesson Shares To Underperform
06:22AM  McKesson downgraded by Credit Suisse
Nov-17-16 10:30AM  Analysis of AmerisourceBergen's Dividend Increase
Nov-16-16 05:25PM  Andrew Left: Dump Mallinckrodt
Nov-11-16 12:56PM  McKesson Falls and Recovers, but Is It Still Undervalued?
08:15AM  Post Earnings Coverage as AmerisourceBergen Q4 Bottomline Outperformed Projections Accesswire
Nov-09-16 08:15AM  Post Earnings Coverage as Cardinal Health Revenue Up 14% Accesswire +8.56%
Nov-08-16 04:13PM  CVS Health Dives On Sales Miss, Earnings Guidance; Walgreens Falls
Nov-07-16 01:00AM  NKE, AGN, NFLX: Jim Cramer's Views
Nov-06-16 11:13AM  Drug Wholesalers Feel Pricing Heat (MCK, ABC) at Investopedia
Nov-04-16 07:21PM  Samuel Isaly Makes 9 New Buys in 3rd Quarter
07:01PM  Cramer: Don't Just Stand There Like Bambi; Sell Some
10:28AM  The path of the economy depends on this election
Nov-03-16 07:30PM  Drugmakers under fire for possible U.S. price fixing Reuters
12:44PM  Top 5 medical distributors with good fundamentals : November 3, 2016
10:36AM  Moving Average Crossover Alert: McKesson (MCK)
Nov-02-16 01:04PM  MCKESSON CORP Financials +5.07%
Nov-01-16 06:59PM  Why Cardinal Health Is My Favorite Health Care Stock
12:09PM  ETFs with exposure to McKesson Corp. : November 1, 2016
10:39AM  The Election Can't Come Soon Enough For Biotechs
10:38AM  New Strong Sell Stocks for November 1st
12:03AM  [$$] Overheard: For Stocks, Theres Nothing Funny About Misunderstanding at The Wall Street Journal
Oct-31-16 07:01PM  Cramer: Investors Look at Merck, Wondering Why They Did Not Buy Qualcomm
06:48PM  Federal Probe Is No Halloween Treat for Valeant
04:54PM  Cardinal Health Lowers The Temperature On Sector With Q1 Results
02:33PM  Drug stocks bounce even as pricing problems spread at MarketWatch
10:41AM  Jim Cramer -- Health Care Could Be Susceptible to More Declines
10:21AM  Company News for October 31, 2016
09:56AM  McKesson Corp. :MCK-US: Earnings Analysis: Q2, 2017 By the Numbers : October 31, 2016
07:00AM  Trader's Daily Notebook: Uncertainty Leads to Assets' Repricing
Oct-29-16 12:55PM  Drug stocks sink as backlash against price hikes hits bottom lines at MarketWatch
09:00AM  Jim Cramer's Top Takeaways: Amerisource Bergen, Avon And More
12:13AM  [$$] McKesson Sounds the Drug-Price Alarm at The Wall Street Journal
12:11AM  [$$] Backlash Against Drug Prices Hits Manufacturers and Middlemen at The Wall Street Journal
Oct-28-16 06:39PM  McKesson Corp (MCK) Stock Down Over 24% Today -22.67%
06:27PM  Cramer: The drug wholesale price war has officially begun steer clear at CNBC
06:15PM  Cramer: The drug wholesale price war has officially begun...
06:09PM  Why Amgen, McKesson, and Stonemor Partners Slumped Today at Motley Fool
05:03PM  [$$] Backlash Against Drug Prices Hits Manufacturers and Middlemen at The Wall Street Journal
04:56PM  Stocks wilt after FBI inquiry into new Clinton emails
04:35PM  McKesson Takes a Hit on Earnings, Drags Cardinal and Amerisource Bergan Down With It
04:26PM  McKesson Drags Down Sector With Earnings Miss, Lower Outlook
04:04PM  McKesson, Nokia Settle into Fridays 52-Week Low Club at 24/7 Wall St.
03:51PM  Healthcare & biotech sell off
03:47PM  The Unusual Argument Explaining Why Drug Wholesalers Are Getting Slammed Today at Motley Fool
03:04PM  Stressed Out: Valeant Shareholders Flee on McKesson Warning
02:43PM  Cardinal Health (CAH) Stock Tumbles on Pricing Concerns
02:06PM  [$$] Warning of a Price War Among Drug Wholesalers Sends Shares Sliding at The Wall Street Journal
01:43PM  Why McKesson's Stock Is Tumbling 24% Today at Motley Fool
01:35PM  Stocks Reverse Higher As Facebook, Alphabet Help The Nasdaq; Medicals Routed
12:35PM  U.S. drug wholesaler shares tumble on pricing-war fears
12:07PM  Why AmerisourceBergen (ABC) Stock Is Plummeting Today
12:00PM  Trading healthcare's sell-off
12:00PM  Jim Cramer Explains Why Health Care Stocks are Getting Slammed on Wall Street Today at TheStreet
11:46AM  [$$] McKesson Sounds the Drug-Price Alarm at The Wall Street Journal
11:42AM  McKesson misses earnings, cuts outlook amid drug pricing scrutiny; shares plunge at CNBC
10:39AM  McKesson tumbles
10:35AM  Stocks Edge Up; Nasdaq Sags As Amazon Weighs; Chevron Boosts Dow
10:16AM  Jim Cramer -- McKesson's Guidance Cut Was a Big Surprise
10:15AM  McKesson (MCK) Stock Plummets on Q2 Results, Guidance Cut
10:07AM  Stocks Mixed; Q3 GDP Positive; Baker-Hughes, Sanofi Spike
09:49AM  Drug wholesalers are getting slammed after McKesson warned that cost scrutiny is hurting its business
08:53AM  Early movers: AMZN, GOOGL, BHI, MCK, HSY, UBS, NVO, SNY, BUD & more at CNBC
08:27AM  Morning Movers: AbbVie Drops as Sales Disappoint; McKesson Crumbles at Barrons.com
08:24AM  McKesson (MCK) Misses on Q2 Earnings & Sales, Cuts View
Oct-27-16 10:51PM  Edited Transcript of MCK earnings conference call or presentation 27-Oct-16 9:00pm GMT
09:31PM  McKesson Dives on Falling Earnings, Weak Guidance at Motley Fool
05:38PM  [$$] McKesson Shares Slide as Outlook Slashed at The Wall Street Journal
04:39PM  McKesson misses Street 2Q forecasts
04:36PM  McKesson EPS & revenues below Street expectations
04:29PM  McKesson shares drop on earnings miss, weak outlook at MarketWatch
04:21PM  MCKESSON CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:20PM  McKesson Declares Quarterly Dividend October 27, 2016 Business Wire
04:10PM  McKesson Reports Fiscal 2017 Second-Quarter Results and Revised Fiscal 2017 Outlook Business Wire
07:07AM  Q2 2017 McKesson Corp Earnings Release - After Market Close
Oct-26-16 08:31AM  Dental Stocks' Earnings to Watch on Oct 27: MCK, WST, CNMD
Oct-25-16 11:13AM  4 Health Care Stock Picks for Your Long-Term Portfolio
Oct-24-16 01:14PM  Walgreens Delivers an Earnings Beat Once Again
Oct-21-16 08:36AM  McKesson (MCK) Q2 Earnings: Stock Likely to Disappoint?
Oct-20-16 04:10PM  McKesson Corporation to Present at the 25th Annual Credit Suisse Healthcare Conference Business Wire
Oct-17-16 08:04AM  Evaluating Walgreens Top-Line Growth
Oct-14-16 11:49AM  McKesson Corp. : MCK-US: Dividend Analysis : September 01st, 2016 (record date) : By the numbers : October 14, 2016
Oct-06-16 04:10PM  McKesson Corporation Fiscal 2017 Second Quarter Conference Call Scheduled for October 27, 2016 Business Wire
Oct-04-16 08:27AM  3 Beaten-Up Healthcare Stocks: Are They Bargains? at Motley Fool
Oct-03-16 01:45PM  Vanilla shortage in Madagascar might mean price hikes at McCormick at bizjournals.com
Sep-20-16 11:49AM  McKesson Launches Intelligence Hub (MKC) at Investopedia
Sep-19-16 11:19AM  Generic Drug Price Deflation Is Weighing On McKesson Shares
Sep-16-16 10:12AM  McKesson's Correction Is not Just a Third-Quarter Issue
Sep-15-16 04:45PM  McKesson Could Return As Much As 17.5%, Vetr Crowd Says
12:37PM  One Reason Why McKesson (MCK) Stock Is Under Pressure Today
11:28AM  German antitrust watchdog raids drugs distributors Reuters
Sep-14-16 01:36PM  Nasdaq Leads, Dow Stocks Higher As Telecom Sector Heats Up
01:30PM  The Dirty Little Secret Goldman Doesn't Want You To Know...
Sep-13-16 08:15PM  Mckesson Corp (MCK) Chairman, President & CEO John H Hammergren Sold $18.2 million of Shares
Sep-12-16 04:46PM  4 Cheap Pharma Stocks to Buy No Matter Who Is Elected
02:01PM  Ignore the Political Debate and Buy These 4 Cheap Pharma Stocks at TheStreet
McKesson Corporation operates as a pharmaceutical distribution services and information technology company in the United States and internationally. It offers pharmaceuticals and medical supplies, and services for healthcare operations. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. This segment also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, equipment, logistics, and other services to healthcare providers. In addition, this segment operates retail pharmacies in Europe and supports independent pharmacy networks in North America; sells financial, operational, and clinical solutions to pharmacies; and provides consulting, outsourcing, and other services. The McKesson Technology Solutions segment delivers enterprise-wide clinical, patient care, financial, supply chain, and strategic management technology solutions; and connectivity, outsourcing, and other services, including remote hosting and managed services to healthcare organizations. This segment's product portfolio addresses various healthcare clinical and business performance needs ranging from medication safety and information access to revenue cycle management, resource utilization, and physician adoption of electronic health records. This segment serves integrated delivery networks, hospitals, physician practices, home healthcare providers, retail pharmacies, and payers. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BUDD WAYNE ADirectorDec 05Sale145.77723105,3920Dec 06 06:44 PM
Schechter Lori A.EVP, GC & Chief Compl. OfficerNov 30Buy144.52692100,0076,843Dec 01 06:58 PM
SALKA SUSAN RDirectorNov 02Buy136.351,000136,3512,005Nov 03 05:54 PM
McElligott Kathleen D.EVP, CIO & CTONov 01Option Exercise0.007830783Nov 02 06:49 PM
Lampert Erin MSVP & ControllerOct 31Sale123.99921114,1950Oct 31 05:48 PM
Lampert Erin MSVP & ControllerOct 29Option Exercise0.001,76501,765Oct 31 05:48 PM
BEER JAMES AEVP & Chief Financial OfficerOct 09Option Exercise0.006,416018,828Oct 11 06:04 PM
Lampert Erin MSVP & ControllerOct 03Sale165.941,739288,5700Oct 04 05:41 PM
HAMMERGREN JOHN HChairman, President & CEOSep 12Option Exercise67.81100,5006,814,905100,500Sep 13 05:42 PM
BUDD WAYNE ADirectorSep 12Sale179.702,309414,920723Sep 13 05:27 PM
HAMMERGREN JOHN HChairman, President & CEOSep 12Sale180.77100,50018,166,9630Sep 13 05:42 PM
HAMMERGREN JOHN HChairman, President & CEOSep 06Option Exercise67.81100,5006,814,905100,500Sep 07 08:21 PM
HAMMERGREN JOHN HChairman, President & CEOSep 06Sale184.22100,50018,513,9390Sep 07 08:21 PM
JACOBS M CHRISTINEDirectorAug 22Sale193.78915177,3120Aug 23 07:02 PM
KNOWLES MARIE L/CADirectorAug 01Sale192.73915176,3480Aug 01 05:36 PM
BEER JAMES AEVP & Chief Financial OfficerJul 14Sale199.005,5001,094,50012,412Jul 15 04:50 PM
HAMMERGREN JOHN HChairman, President & CEOMay 25Sale183.6718,7113,436,6960May 25 07:44 PM
Schechter Lori A.EVP, GC & Chief Compl. OfficerMay 25Sale183.6710819,8376,151May 25 07:40 PM
JULIAN PAUL CEVP, Group PresidentMay 25Sale183.6710,1161,858,03157May 25 07:36 PM
Blake PatrickEVP, Group PresidentMay 25Sale183.673,161580,5892,167May 25 07:31 PM
HAMMERGREN JOHN HChairman, President & CEOMay 24Sale182.0618,7093,406,18118,711May 25 07:44 PM
Schechter Lori A.EVP, GC & Chief Compl. OfficerMay 24Sale182.0610719,4816,259May 25 07:40 PM
JULIAN PAUL CEVP, Group PresidentMay 24Sale182.0610,1161,841,73010,173May 25 07:36 PM
Blake PatrickEVP, Group PresidentMay 24Sale182.063,161575,4955,328May 25 07:31 PM
Schechter Lori A.EVP, GC & Chief Compl. OfficerMay 23Sale179.3310719,1896,366May 23 08:17 PM
HAMMERGREN JOHN HChairman, President & CEOMay 23Sale179.3318,7183,356,76837,420May 23 07:49 PM
Blake PatrickEVP, Group PresidentMay 23Sale179.333,162567,0538,489May 23 07:45 PM
REES NIGEL ASVP & ControllerMay 21Option Exercise0.002,07907,079May 23 08:23 PM
Schechter Lori A.EVP, GC & Chief Compl. OfficerMay 21Option Exercise0.001,93507,483May 23 08:17 PM
Figueredo JorgeEVP, Human ResourcesMay 21Option Exercise0.0015,000015,000May 23 08:13 PM
HAMMERGREN JOHN HChairman, President & CEOMay 21Option Exercise0.0094,000094,000May 23 07:49 PM
Blake PatrickEVP, Group PresidentMay 21Option Exercise0.0018,000020,167May 23 07:45 PM
HAMMERGREN JOHN HChairman, President & CEOMay 10Option Exercise40.46101,8334,120,163101,833May 10 07:26 PM
HAMMERGREN JOHN HChairman, President & CEOMay 10Sale170.71101,83317,384,3800May 10 07:26 PM
HAMMERGREN JOHN HChairman, President & CEOApr 04Option Exercise40.4645,3001,832,83845,300Apr 05 06:44 PM
HAMMERGREN JOHN HChairman, President & CEOApr 04Sale159.0045,3007,202,8990Apr 05 06:44 PM
REES NIGEL ASVP & ControllerMar 15Option Exercise40.4611,000445,06011,000Mar 16 06:49 PM
REES NIGEL ASVP & ControllerMar 15Sale157.596,000945,5415,000Mar 16 06:49 PM
SALKA SUSAN RDirectorFeb 02Buy156.211,000156,2111,000Feb 03 05:28 PM
Schechter Lori A.EVP, GC & Chief Compl. OfficerFeb 01Sale159.732,476395,5025,548Feb 02 06:05 PM
Schechter Lori A.EVP, GC & Chief Compl. OfficerJan 24Option Exercise0.0013,064013,873Jan 25 05:55 PM
HAMMERGREN JOHN HChairman, President & CEOJan 04Option Exercise40.46101,8334,120,163101,833Jan 05 06:31 PM
HAMMERGREN JOHN HChairman, President & CEOJan 04Sale194.11101,83319,766,4780Jan 05 06:31 PM